TY  - JOUR
EP  - 104
N2  - Chronic kidney disease-associated pruritus (CKD-aP) is a common and distressing symptom for patients with CKD and a difficult challenge for nephrologists and dermatologists. Recent results showed the multifactorial nature of the pathophysiology, and therapeutic trials were only successful in certain subsets of patients. The clinical manifestations are varied, with xerosis being the most common dermatological manifestation and correlated with the intensity of CKD-aP. A better understanding of the pathophysiology of xerosis in CKD-aP and appropriate topical treatment could correct xerosis to reduce the intensity of CKD-aP and improve the patient's quality of life.
A1  - Arum Krismi
A1  - Retno Danarti
A1  - Yohanes Widodo Wirohadidjojo
A1  - Ida I Dewa Putu Pramantara Setiabudi
PB  - Wiley-Blackwell
UR  - https://doi.org/10.1111/hdi.13071
TI  - CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS IN PATIENTS UNDERGOING HEMODIALYSIS: XEROSIS AND TOPICAL THERAPY
IS  - 2
SN  - 1542-4758
Y1  - 2023/02/22/
ID  - katalog9058
SP  - 91
VL  - 27
KW  - chronic kidney disease
KW  -  moisturizers
KW  -  pruritus
KW  -  topical treatment
KW  -  xerosis
AV  - public
JF  - Journal Hemodialysis International
ER  -